Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9076 |
High Similarity |
NPD9493 |
Approved |
0.8926 |
High Similarity |
NPD9545 |
Approved |
0.8915 |
High Similarity |
NPD1240 |
Approved |
0.8779 |
High Similarity |
NPD1607 |
Approved |
0.8731 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8647 |
High Similarity |
NPD1510 |
Phase 2 |
0.8561 |
High Similarity |
NPD230 |
Phase 1 |
0.8456 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8444 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8425 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8403 |
Intermediate Similarity |
NPD74 |
Approved |
0.8403 |
Intermediate Similarity |
NPD9266 |
Approved |
0.8382 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8319 |
Intermediate Similarity |
NPD9263 |
Approved |
0.8319 |
Intermediate Similarity |
NPD9264 |
Approved |
0.8319 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.8319 |
Intermediate Similarity |
NPD9267 |
Approved |
0.8286 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8231 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8138 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8099 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8074 |
Intermediate Similarity |
NPD943 |
Approved |
0.806 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7983 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7972 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7972 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7972 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7972 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7969 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7945 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7923 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7914 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7905 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7905 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7872 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7842 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7823 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.782 |
Intermediate Similarity |
NPD1164 |
Approved |
0.78 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7794 |
Intermediate Similarity |
NPD411 |
Approved |
0.7793 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7761 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7754 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7748 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7746 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD920 |
Approved |
0.7718 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7708 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7677 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7667 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7664 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7662 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7622 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7619 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7616 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD520 |
Approved |
0.7603 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7589 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7459 |
Intermediate Similarity |
NPD940 |
Approved |
0.7459 |
Intermediate Similarity |
NPD846 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7413 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7413 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7413 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7413 |
Intermediate Similarity |
NPD5404 |
Approved |
0.741 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7376 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7355 |
Intermediate Similarity |
NPD919 |
Approved |
0.7353 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7328 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7297 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD1201 |
Approved |
0.725 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7218 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7215 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7208 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7205 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7054 |
Approved |
0.72 |
Intermediate Similarity |
NPD9509 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7163 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7162 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6190 |
Approved |
0.716 |
Intermediate Similarity |
NPD7472 |
Approved |
0.716 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7099 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.708 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.708 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD164 |
Approved |
0.7059 |
Intermediate Similarity |
NPD9258 |
Approved |
0.7059 |
Intermediate Similarity |
NPD9256 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7031 |
Intermediate Similarity |
NPD1358 |
Approved |
0.703 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7016 |
Intermediate Similarity |
NPD1238 |
Approved |
0.7014 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7007 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7007 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.6985 |
Remote Similarity |
NPD17 |
Approved |
0.6981 |
Remote Similarity |
NPD5494 |
Approved |
0.698 |
Remote Similarity |
NPD7003 |
Approved |
0.6963 |
Remote Similarity |
NPD1759 |
Phase 1 |
0.696 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6953 |
Remote Similarity |
NPD3134 |
Approved |
0.6951 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6948 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6944 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD6099 |
Approved |
0.6939 |
Remote Similarity |
NPD6100 |
Approved |
0.6937 |
Remote Similarity |
NPD1247 |
Approved |
0.6929 |
Remote Similarity |
NPD3266 |
Approved |
0.6929 |
Remote Similarity |
NPD3267 |
Approved |
0.6928 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6909 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6889 |
Remote Similarity |
NPD1758 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD1196 |
Approved |
0.6866 |
Remote Similarity |
NPD255 |
Approved |
0.6866 |
Remote Similarity |
NPD256 |
Approved |
0.6861 |
Remote Similarity |
NPD4626 |
Approved |
0.6859 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD1283 |
Approved |
0.6852 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD2182 |
Approved |
0.6839 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6838 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6835 |
Remote Similarity |
NPD5353 |
Approved |
0.6821 |
Remote Similarity |
NPD2354 |
Approved |
0.6812 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6806 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6803 |
Remote Similarity |
NPD9279 |
Approved |
0.68 |
Remote Similarity |
NPD1195 |
Approved |
0.6797 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6791 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD4287 |
Approved |
0.6774 |
Remote Similarity |
NPD1653 |
Approved |
0.6766 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6753 |
Remote Similarity |
NPD2186 |
Approved |
0.675 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6748 |
Remote Similarity |
NPD1202 |
Approved |
0.6744 |
Remote Similarity |
NPD9697 |
Approved |
0.6744 |
Remote Similarity |
NPD5048 |
Discontinued |
0.6742 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6738 |
Remote Similarity |
NPD1876 |
Approved |
0.6732
|
Remote Similarity |
NPD1543 |
Discontinued |